Metropolis Network Expansion and Revenue Growth Strategy

Q3FY24 Performance Snapshot 3. & گاه Q3FY24 Key Highlights METROPOLIS The Pathology Specialist Total Revenue Rs. 291 Crores 2% YoY Core Business* Revenue Rs. 286 Crores 12% YoY Core Business* Patient Vol. 2.83 Mn 9% YoY Core Business* Test Vol. 5.81 Mn 11% YoY Core Business* RPP Rs. 1,009 3% YoY Core Business* RPT Rs 492 1% YoY *Core business excludes revenue for Covid & Covid allied and PPP Contracts (incl. Hi-tech) EBITDA Margin (Before CSR & ESOP) 23.6% Reported EBITDA Margin^ 22.5% ^0.8% impact on account of one-time provision for doubtful debt 4

View entire presentation